[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366403-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366403-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","arsenic-sulfide-alleviates-the-progression-of-liver-cancer-malignancy-by-inhibiting-the-expression-of-tlcd1-in-mice","Arsenic sulfide alleviates the progression of liver cancer malignancy by inhibiting the expression of TLCD1 in mice","","Liver cancer drives cancer-related deaths worldwide, yet effective treatments remain lacking and patient outcomes are poor. Arsenic sulfide has shown antitumor activity in hematological malignancies, but its role and mechanism in liver cancer are unclear. This study demonstrates that arsenic sulfide suppresses hepatoma cell proliferation and migration while promoting apoptosis, and it markedly alleviates hepatocellular carcinoma progression in mouse models. Transcriptomic analysis indicates that TLCD1 inhibition underlies reduced tumor malignancy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/arsenic-sulfide-alleviates-the-progression-of-liver-cancer-malignancy-by-inhibiting-the-expression-of-tlcd1-in-mice/366403/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/arsenic-sulfide-alleviates-the-progression-of-liver-cancer-malignancy-by-inhibiting-the-expression-of-tlcd1-in-mice/366403.png","ImageObject",300,407,{"name":42,"@type":43},"supergirl","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does this study address in liver cancer treatment?","Question",{"text":63,"@type":64},"The study targets the lack of effective liver cancer therapies and the poor prognosis of patients, aiming to clarify whether arsenic sulfide can act against liver cancer and how it works.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does arsenic sulfide affect hepatoma cells in the study?",{"text":68,"@type":64},"Arsenic sulfide inhibits hepatoma cell proliferation and migration and promotes apoptosis of hepatoma cell lines.",{"name":70,"@type":61,"acceptedAnswer":71},"What molecular mechanism is proposed for arsenic sulfide’s effect on liver cancer?",{"text":72,"@type":64},"Transcriptomic analysis suggests arsenic sulfide suppresses malignant progression by inhibiting TLCD1 expression, thereby reducing proliferation associated with hepatocellular carcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366403,1790313626,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962088121634,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Li etal. BMC Medical Genomics (2025) 18:128 [https://doi.org/10.1186/s12920-025-02195-4](https://doi.org/10.1186/s12920-025-02195-4)  \nBMC Medical Genomics  \nRESEARCH Open Access  \nArsenic sulfide alleviates the progression of liver cancer malignancy by inhibiting the expression ofTLCD1 in mice  \nXianglu Li 1†, Xuehua Xing 1†, Lin Wang 1* and Shizong Li2*  \nAbstract  \nLiver cancer is the leading cause of cancer deaths worldwide and is the only cancer type among the five deadliest cancers with an increasing incidence each year. The prognosis of liver cancer is poor and no effective treatment for this cancer to date. Arsenic sulfide has been found to be effective in the treatment of hematological malignancies but its therapeutic outcomes and associated mechanisms in liver cancer remain unknown. In this study, we found that arsenic sulfide treatment could effectively inhibit the proliferation, migration and promotion of apoptosis of hepatoma cell lines, and remarkably alleviated the progression of hepatocellular carcinoma in mouse models. Transcriptomic analysis of the HepG2 cell line treated with arsenic sulfide showed that arsenic sulfide inhibited the proliferation of hepatoma cells by inhibiting the expression ofTriacylglycerol and Lipid Catabolism Deficient 1 (TLCD1), thereby alleviating the malignant progression of hepatocellular carcinoma. This study provides a molecular basis for arsenic sulfide in the treatment of liver cancer.  \nKeywords Liver cancer, Arsenic sulfide, TLCD1, Transcriptomic analysis  \nIntroduction  \nLiver cancer is the leading cause of cancer-related deaths worldwide, and it is the only one among the top five deadliest cancers that sees an annual increase in incidence [1]. The incidence of liver disease is even higher in developing countries [2, 3]. The prognosis for liver cancer is poor. Only 5–15% of patients are eligible for surgical  \n†Xianglu Li and Xuehua Xing contributed equally to this work.  \n*Correspondence: Lin Wang [wanglin7209@163.com](wanglin7209@163.com)[ ](wanglin7209@163.com)Shizong Li[lishizongshanda@163.com](lishizongshanda@163.com)  \n1Medical Oncology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province 570311, China 2Department of Hepatobiliary and Pancreatic Surgery, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan Province 570311, China  \nresection, which is only applicable to early-stage patients and typically not those with cirrhosis due to decreased liver regenerative capacity; the risk of postoperative complications for right hepatectomy is higher than for left hepatectomy. Long-term use of chemotherapy drugs (such as sorafenib) presents other issues, such as toxicity and/or drug resistance [4, 5]. Therefore, current ablation therapies and chemotherapy have not shown significant effectiveness in improving the prognosis of this devastating disease. Further research is necessary to find better treatment methods for liver cancer.  \nArsenic trioxide(As4S4) is a key component of the traditional Chinese medicine “realgar”, and it has a long history of use as an antitumor agent in traditional Chinese medicine [6]. Modern research has also found that it has good clinical prospects in certain cancers, especially in hematological malignancies such as acute promyelocytic leukemia (APL), where it has shown good efficacy [7].  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third","cbCaicD0M3uUashh","https://ap.wps.com/l/cbCaicD0M3uUashh","pdf",6158001,14,"English","# Abstract\n## Background and rationale\n## Study findings and mechanisms\n## Clinical and translational significance","[{\"question\":\"What problem does this study address in liver cancer treatment?\",\"answer\":\"The study targets the lack of effective liver cancer therapies and the poor prognosis of patients, aiming to clarify whether arsenic sulfide can act against liver cancer and how it works.\"},{\"question\":\"How does arsenic sulfide affect hepatoma cells in the study?\",\"answer\":\"Arsenic sulfide inhibits hepatoma cell proliferation and migration and promotes apoptosis of hepatoma cell lines.\"},{\"question\":\"What molecular mechanism is proposed for arsenic sulfide’s effect on liver cancer?\",\"answer\":\"Transcriptomic analysis suggests arsenic sulfide suppresses malignant progression by inhibiting TLCD1 expression, thereby reducing proliferation associated with hepatocellular carcinoma.\"}]","Arsenic sulfide alleviates the progression of liver cancer malignancy by inhibiting the expression of TLCD1 in mice | PDF",1790165337,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4df7ae62574079b4a1a2b18006a3d36.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e8f2a82fbb6dc20477940d250f3301e.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/40e5474fd9a968ae68ba4e1472984a57.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4052a8587bd8207cb000a33be9a31a2f.webp",980,1306]